By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Nanosphere rose sharply for the second month in a row, climbing 32 percent in April, to lead all stocks in the GenomeWeb Daily News Index.

Nanosphere led a handful of companies whose stocks rose in the double digits, while CombiMatrix had the steepest decline amid its newly announced restructuring.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.